Metastatic HR + HER2 - breast cancer
Also known as: Metastatic Breast Cancer HR+, HER2- / Metastatic HR+ HER2- breast cancer / HR+ HER2- metastatic breast cancer
Drug | Drug Name | Drug Description |
---|---|---|
DB12001 | Abemaciclib | A medication used to treat HR+ HER2- advanced or metastatic breast cancer. |
DB12015 | Alpelisib | Alpelisib is indicated in combination with fulvestrant to treat postmenopausal women, and men, with advanced or metastatic breast cancer. This cancer must be hormone receptor (HR)-positive, human epidermal growth factor... |
DB01006 | Letrozole | An aromatase inhibitor used to treat breast cancer in postmenopausal women. |
Drug | Drug Name | Phase | Status | Count |
---|